Runx2 and Axin2 Interactions During Bone Formation
Runx2 and Axin2 Interactions During Bone Formation
批准号:
8334718
负责人:
Elizabeth W Bradley
金额:
$5.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-04 至 2013-08-03
关键词:
AdultAffectAnabolic AgentsAntibodiesBindingBiologyBone MarrowBone RegenerationBone ResorptionCalvariaCartilageCell Differentiation processCellsChondrocytesCleidocranial DysplasiaCoculture TechniquesComplexCraniosynostosisDefectDevelopmentDiseaseElementsEmbryoEmbryonic DevelopmentExhibitsFeedbackFellowshipGenetic ModelsGenotypeHypertrophyIn VitroKnock-outKnockout MiceLaboratoriesMaintenanceMediatingMesenchymal DifferentiationModelingMolecularMusNatural regenerationOsteoblastsOsteoclastsOsteogenesisOsteopeniaPhenotypePhysiologicalPlayPostdoctoral FellowProcessPropertyRelative (related person)ResearchRoleScaffolding ProteinSignal PathwaySignal TransductionStromal CellsTechniquesTestingTissuesTrainingTumor Suppressor ProteinsWorkX-Ray Computed Tomographybonebone cellbone massbone strengthcarcinogenesiscareercareer developmentdensityextracellularinhibitor/antagonistintramembranous bone formationlong bonemacrophagemeetingsmouse developmentmutantosteoblast differentiationpostnatalpromoterskeletalskillsspine bone structuresubstantia spongiosatranscription factor
中文摘要
项目描述(申请人提供):本项目探讨骨修复/再生和最佳骨量积累和维持的两个关键调控因子Runx2和Axin2之间的分子和生理相互作用。Runx2 (Cbfa1)是成骨细胞发生和软骨细胞肥大所需的转录因子。runx2缺乏症在出生后是致命的,而runx2单倍体不足会导致锁骨颅发育不良(CCD)和骨质减少。唯一已知的至少部分挽救Runx2小鼠表型的生物学方法是抑制Gsk3- 2。Axin2是一种限制浓度的脚手架蛋白,它将Gsk3-2、2-catenin和其他组分组装成2-catenin破坏复合物。Axin2是典型Wnt信号的负反馈调节因子,可减缓成骨细胞的增殖。有趣的是,敲除Axin2的小鼠具有较高的骨小梁骨量。因此,axin2缺乏和runx2单倍不足导致相反的小梁骨表型。我们发现,在runx2缺陷细胞中,Axin2水平升高。该项目的中心假设是Runx2通过主动抑制Axin2和增强骨细胞中的Wnt/2-catenin信号传导来促进骨量和强度。本研究的目的是定量评估“双突变”Runx2:Axin2-/-小鼠相对于“单突变”Runx2或Axin2-/-小鼠的表型,并确定Runx2和Axin2之间的相互作用是否调节骨细胞分化。
英文摘要
DESCRIPTION (provided by applicant): This project explores the molecular and physiological interactions between two crucial regulators of bone repair/regeneration and optimal bone mass accrual and maintenance: Runx2 and Axin2. Runx2 (Cbfa1) is a transcription factor required for osteoblastogenesis and chondrocyte hypertrophy. Runx2-deficiency is postnatally lethal, whereas Runx2-haploinsufficiency causes cleidocranial dysplasia (CCD) and osteopenia. The only known biologic means to at least partially rescue the phenotype in Runx2 mice is by inhibiting Gsk3- 2. Axin2 is a concentration-limiting scaffolding protein that assembles Gsk3-2, 2-catenin and other components into the 2-catenin destruction complex. Axin2 is a negative feedback regulator of canonical Wnt signaling and slows osteoblast proliferation. Interestingly, Axin2 knockout mice have high trabecular bone mass. Thus, Axin2-deficiency and Runx2-haploinsufficiency cause opposing trabecular bone phenotypes. We show that Axin2 levels are increased in Runx2-deficient cells. The central hypothesis of this project is that Runx2 promotes bone mass and strength by actively repressing Axin2 and enhancing Wnt/2-catenin signaling in bone cells. The objective of this proposal is to quantitatively assess the phenotypes of "double mutant" Runx2:Axin2-/- mice relative to "single mutant" Runx2 or Axin2-/- mice and to determine if the interaction between Runx2 and Axin2 regulates bone cell differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:10001986
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:10237904
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:9761459
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Epigenetic Regulation of Phlpp1 in Cartilage Development and Regeneration
-
批准号:8893005
-
项目类别:
-
资助金额:$10.39万
-
财政年份:2014
-
负责人:Elizabeth W Bradley
-
依托单位:
Runx2 and Axin2 Interactions During Bone Formation
-
批准号:8195738
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2011
-
负责人:Elizabeth W Bradley
-
依托单位:
海外基金